| 1 |
35384248 | Evaluation of the therapeutic potential of masitinib and expression of its specific targets c-Kit, PDGFR-α, PDGFR-β, and Lyn in canine prostate cancer cell lines. | 2022 Apr 5 |
1 |
| 2 |
28069279 | Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study. | 2017 Feb 11 |
1 |
| 3 |
20209107 | Masitinib combined with standard gemcitabine chemotherapy: in vitro and in vivo studies in human pancreatic tumour cell lines and ectopic mouse model. | 2010 Mar 4 |
1 |